BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

945 related articles for article (PubMed ID: 7658531)

  • 21. [Carcinoma of the urethra in patients having undergone cystectomy for neoplasm of the bladder].
    Vicini D; Mensi M; Mirando P; Scoppetta FP
    Arch Ital Urol Nefrol Androl; 1989 Sep; 61(3):217-21. PubMed ID: 2529636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Indications for one-stage and delayed urethrectomy after radical cystectomy in patients with invasive cancer of the urinary bladder].
    Darenkov SP; Gorilovskiĭ ML; Chernyshev IV; Akmatov NA
    Urologiia; 2003; (5):5-8. PubMed ID: 14658263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy.
    Shariat SF; Palapattu GS; Karakiewicz PI; Rogers CG; Vazina A; Bastian PJ; Schoenberg MP; Lerner SP; Sagalowsky AI; Lotan Y
    Eur Urol; 2007 Jan; 51(1):152-60. PubMed ID: 17011114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection.
    Holzbeierlein JM; Lopez-Corona E; Bochner BH; Herr HW; Donat SM; Russo P; Dalbagni G; Sogani PC
    J Urol; 2004 Sep; 172(3):878-81. PubMed ID: 15310988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Robot-assisted radical cystectomy and urinary diversion in female patients: technique with preservation of the uterus and vagina.
    Menon M; Hemal AK; Tewari A; Shrivastava A; Shoma AM; Abol-Ein H; Ghoneim MA
    J Am Coll Surg; 2004 Mar; 198(3):386-93. PubMed ID: 14992741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indications for urethrectomy.
    Elmajian DA
    Semin Urol Oncol; 2001 Feb; 19(1):37-44. PubMed ID: 11246732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Urethral recurrence after cysto-prostatectomy for bladder tumor].
    Robert M; Burgel JS; Serre I; Guiter J; Grasset D
    Prog Urol; 1996; 6(4):558-63. PubMed ID: 8924933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Transitional cell carcinoma of the prostate in cystoprostatectomy specimens].
    Liedberg F; Chebil G; Davidsson T; Malmström PU; Sherif A; Månsson W
    Aktuelle Urol; 2003 Sep; 34(5):333-6. PubMed ID: 14566661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective study of transitional cell carcinoma in the prostatic urethra and prostate in the cystoprostatectomy specimen. Incidence, characteristics and preoperative detection.
    Liedberg F; Anderson H; Bläckberg M; Chebil G; Davidsson T; Gudjonsson S; Jahnson S; Olsson H; Månsson W
    Scand J Urol Nephrol; 2007; 41(4):290-6. PubMed ID: 17763219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance.
    Shen SS; Lerner SP; Muezzinoglu B; Truong LD; Amiel G; Wheeler TM
    Hum Pathol; 2006 Jun; 37(6):726-34. PubMed ID: 16733214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Radical cystectomy for superficial tumors in the BCG era].
    Huguet Pérez J; Palou J; Millán Rodríguez F; Villavicencio Mavrich H; Rodríguez JV
    Arch Esp Urol; 2002; 55(1):50-6. PubMed ID: 11957752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urethral recurrence in patients following orthotopic urinary diversion.
    Hassan JM; Cookson MS; Smith JA; Chang SS
    J Urol; 2004 Oct; 172(4 Pt 1):1338-41. PubMed ID: 15371836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncological outcome after radical cystectomy and orthotopic bladder substitution in women.
    Ali-El-Dein B
    Eur J Surg Oncol; 2009 Mar; 35(3):320-5. PubMed ID: 18434072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of urethral wash cytology in the retained male urethra after radical cystoprostatectomy.
    Lin DW; Herr HW; Dalbagni G
    J Urol; 2003 Mar; 169(3):961-3. PubMed ID: 12576822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of the patient with bladder cancer. Urethral recurrence.
    Freeman JA; Esrig D; Stein JP; Skinner DG
    Urol Clin North Am; 1994 Nov; 21(4):645-51. PubMed ID: 7974896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Urethral recurrence and distant metastases of bladder cancer 9 years after cystectomy and neobladder].
    Kato S; Ito Y; Nishino Y; Ban Y; Deguchi T
    Hinyokika Kiyo; 2005 Mar; 51(3):195-7. PubMed ID: 15852676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
    Huguet J; Crego M; Sabaté S; Salvador J; Palou J; Villavicencio H
    Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.